| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracorporeal Membrane Oxygenation | 11 | 2022 | 197 | 2.020 |
Why?
|
| Abnormalities, Multiple | 5 | 2013 | 236 | 1.170 |
Why?
|
| Heart Defects, Congenital | 8 | 2022 | 367 | 1.090 |
Why?
|
| Respiration, Artificial | 3 | 2015 | 361 | 0.750 |
Why?
|
| Infant | 25 | 2022 | 3183 | 0.710 |
Why?
|
| Parenchymal Tissue | 1 | 2020 | 6 | 0.690 |
Why?
|
| Pleura | 1 | 2020 | 32 | 0.670 |
Why?
|
| Infant, Newborn | 22 | 2022 | 2501 | 0.670 |
Why?
|
| Pulmonary Artery | 4 | 2013 | 324 | 0.660 |
Why?
|
| Hypoplastic Left Heart Syndrome | 4 | 2022 | 77 | 0.540 |
Why?
|
| Heart Septal Defects, Ventricular | 3 | 2022 | 70 | 0.530 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2020 | 269 | 0.520 |
Why?
|
| Aneurysm | 3 | 2007 | 60 | 0.520 |
Why?
|
| Child, Preschool | 16 | 2020 | 3765 | 0.510 |
Why?
|
| Cardiopulmonary Bypass | 4 | 2012 | 160 | 0.510 |
Why?
|
| Heart-Assist Devices | 4 | 2015 | 822 | 0.450 |
Why?
|
| Cineangiography | 1 | 2013 | 13 | 0.450 |
Why?
|
| Tracheobronchomalacia | 1 | 2013 | 11 | 0.440 |
Why?
|
| Vascular Malformations | 1 | 2013 | 19 | 0.440 |
Why?
|
| Retrospective Studies | 22 | 2022 | 9323 | 0.430 |
Why?
|
| Atrial Appendage | 1 | 2013 | 35 | 0.430 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2013 | 15 | 0.420 |
Why?
|
| Norwood Procedures | 2 | 2022 | 40 | 0.400 |
Why?
|
| Intra-Abdominal Hypertension | 1 | 2012 | 5 | 0.400 |
Why?
|
| Lactates | 2 | 2022 | 36 | 0.390 |
Why?
|
| Heart Block | 1 | 2012 | 31 | 0.390 |
Why?
|
| Heart Transplantation | 3 | 2015 | 744 | 0.380 |
Why?
|
| Hemodynamics | 6 | 2022 | 739 | 0.380 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2010 | 67 | 0.360 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2012 | 201 | 0.360 |
Why?
|
| Child | 15 | 2022 | 7216 | 0.340 |
Why?
|
| Expectorants | 1 | 2009 | 6 | 0.330 |
Why?
|
| Deoxyribonucleases | 1 | 2009 | 29 | 0.330 |
Why?
|
| Pulmonary Atelectasis | 1 | 2009 | 19 | 0.330 |
Why?
|
| Patient Transfer | 1 | 2010 | 100 | 0.320 |
Why?
|
| Aorta | 2 | 2007 | 291 | 0.310 |
Why?
|
| Registries | 1 | 2013 | 812 | 0.300 |
Why?
|
| Heart Failure | 2 | 2015 | 1270 | 0.300 |
Why?
|
| Treatment Outcome | 15 | 2022 | 8373 | 0.300 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2013 | 2702 | 0.280 |
Why?
|
| Female | 29 | 2022 | 46855 | 0.280 |
Why?
|
| Tetralogy of Fallot | 2 | 2012 | 44 | 0.270 |
Why?
|
| Humans | 42 | 2023 | 90569 | 0.260 |
Why?
|
| Critical Care | 1 | 2009 | 385 | 0.250 |
Why?
|
| Pulmonary Atresia | 2 | 2004 | 12 | 0.250 |
Why?
|
| Ductus Arteriosus | 2 | 2006 | 27 | 0.240 |
Why?
|
| Decision Making | 1 | 2010 | 672 | 0.230 |
Why?
|
| Time Factors | 7 | 2015 | 5365 | 0.220 |
Why?
|
| Male | 24 | 2022 | 42931 | 0.220 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2023 | 15 | 0.210 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2023 | 33 | 0.210 |
Why?
|
| Arteriovenous Malformations | 1 | 2023 | 45 | 0.200 |
Why?
|
| Sodium Bicarbonate | 1 | 2022 | 9 | 0.200 |
Why?
|
| Cardiac Surgical Procedures | 5 | 2013 | 482 | 0.200 |
Why?
|
| Follow-Up Studies | 6 | 2015 | 3692 | 0.200 |
Why?
|
| Cohort Studies | 5 | 2015 | 2893 | 0.180 |
Why?
|
| Gestational Age | 4 | 2013 | 327 | 0.180 |
Why?
|
| Propranolol | 2 | 2010 | 43 | 0.170 |
Why?
|
| Cough | 1 | 2020 | 55 | 0.170 |
Why?
|
| Hemangioma | 2 | 2010 | 64 | 0.170 |
Why?
|
| Dyspnea | 1 | 2020 | 76 | 0.160 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2010 | 106 | 0.160 |
Why?
|
| Fibrosis | 1 | 2020 | 238 | 0.150 |
Why?
|
| Rhabdomyoma | 1 | 1998 | 3 | 0.150 |
Why?
|
| Ultrasonography | 5 | 2013 | 722 | 0.150 |
Why?
|
| Adolescent | 7 | 2010 | 9353 | 0.150 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2012 | 224 | 0.150 |
Why?
|
| Heart Neoplasms | 1 | 1998 | 64 | 0.140 |
Why?
|
| Echocardiography | 5 | 2010 | 947 | 0.140 |
Why?
|
| Heart Ventricles | 2 | 2022 | 792 | 0.140 |
Why?
|
| Injections, Intravenous | 2 | 2013 | 238 | 0.130 |
Why?
|
| Hospital Mortality | 3 | 2022 | 426 | 0.130 |
Why?
|
| Neuroblastoma | 1 | 2020 | 391 | 0.130 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2022 | 109 | 0.130 |
Why?
|
| Acute-Phase Proteins | 1 | 2015 | 37 | 0.120 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2015 | 53 | 0.120 |
Why?
|
| Antithrombin III | 1 | 2014 | 9 | 0.110 |
Why?
|
| Antithrombins | 1 | 2014 | 17 | 0.110 |
Why?
|
| Cardiac Catheterization | 2 | 2010 | 316 | 0.110 |
Why?
|
| Predictive Value of Tests | 3 | 2013 | 1741 | 0.110 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2013 | 54 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 276 | 0.110 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2013 | 11 | 0.110 |
Why?
|
| Cyanosis | 1 | 2012 | 10 | 0.110 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2013 | 32 | 0.110 |
Why?
|
| Heparin | 1 | 2014 | 186 | 0.100 |
Why?
|
| Constriction, Pathologic | 1 | 2013 | 222 | 0.100 |
Why?
|
| Heart Septum | 1 | 2012 | 47 | 0.100 |
Why?
|
| Cause of Death | 1 | 2014 | 270 | 0.100 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2015 | 198 | 0.100 |
Why?
|
| Intubation, Intratracheal | 1 | 2013 | 148 | 0.100 |
Why?
|
| Hepatitis C, Chronic | 1 | 2013 | 91 | 0.100 |
Why?
|
| Ketamine | 1 | 2012 | 25 | 0.100 |
Why?
|
| Femoral Vein | 1 | 2012 | 39 | 0.100 |
Why?
|
| Respiration | 1 | 2013 | 267 | 0.100 |
Why?
|
| Femoral Artery | 1 | 2012 | 84 | 0.100 |
Why?
|
| Critical Illness | 2 | 2012 | 315 | 0.100 |
Why?
|
| Hepacivirus | 1 | 2013 | 131 | 0.100 |
Why?
|
| Risk Factors | 2 | 2015 | 5580 | 0.100 |
Why?
|
| Jugular Veins | 1 | 2012 | 74 | 0.100 |
Why?
|
| Peritoneal Dialysis | 1 | 2012 | 31 | 0.100 |
Why?
|
| Survival Analysis | 3 | 2012 | 1499 | 0.100 |
Why?
|
| Regression Analysis | 2 | 2010 | 591 | 0.090 |
Why?
|
| Career Choice | 1 | 2013 | 148 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2012 | 100 | 0.090 |
Why?
|
| Drug Administration Schedule | 2 | 2012 | 866 | 0.090 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2012 | 73 | 0.090 |
Why?
|
| Carotid Arteries | 1 | 2012 | 135 | 0.090 |
Why?
|
| Hospitals, Pediatric | 1 | 2012 | 121 | 0.090 |
Why?
|
| Survival Rate | 3 | 2009 | 1899 | 0.090 |
Why?
|
| Adrenal Insufficiency | 1 | 2010 | 23 | 0.090 |
Why?
|
| Postoperative Period | 2 | 2022 | 301 | 0.090 |
Why?
|
| Hospitals, Special | 1 | 2010 | 7 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2014 | 440 | 0.090 |
Why?
|
| Tracheal Neoplasms | 1 | 2009 | 8 | 0.080 |
Why?
|
| Brain Injuries | 1 | 2012 | 167 | 0.080 |
Why?
|
| Length of Stay | 3 | 2022 | 756 | 0.080 |
Why?
|
| Lymphopenia | 1 | 2009 | 30 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2523 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 348 | 0.080 |
Why?
|
| Fetal Heart | 1 | 2009 | 13 | 0.080 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2009 | 32 | 0.080 |
Why?
|
| Pulmonary Ventilation | 1 | 2009 | 33 | 0.080 |
Why?
|
| Anesthesia, General | 1 | 2010 | 118 | 0.080 |
Why?
|
| Biomarkers | 4 | 2022 | 1797 | 0.080 |
Why?
|
| Contrast Media | 1 | 2013 | 1085 | 0.080 |
Why?
|
| Program Evaluation | 1 | 2010 | 311 | 0.080 |
Why?
|
| Intraoperative Complications | 1 | 2010 | 185 | 0.080 |
Why?
|
| Risk Assessment | 2 | 2015 | 2335 | 0.070 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2007 | 9 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2007 | 241 | 0.070 |
Why?
|
| Biliary Atresia | 1 | 2007 | 22 | 0.070 |
Why?
|
| Dilatation, Pathologic | 1 | 2007 | 55 | 0.070 |
Why?
|
| Chromosome Aberrations | 1 | 2009 | 384 | 0.070 |
Why?
|
| Neutrophils | 1 | 2009 | 313 | 0.070 |
Why?
|
| Vena Cava, Superior | 1 | 2007 | 60 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 1015 | 0.070 |
Why?
|
| Fontan Procedure | 2 | 2007 | 56 | 0.070 |
Why?
|
| Syndrome | 1 | 2007 | 452 | 0.070 |
Why?
|
| Foreign Bodies | 1 | 2007 | 66 | 0.070 |
Why?
|
| Incidence | 3 | 2013 | 1594 | 0.070 |
Why?
|
| Inflammation | 1 | 2012 | 990 | 0.070 |
Why?
|
| Methicillin Resistance | 1 | 2006 | 32 | 0.070 |
Why?
|
| Vena Cava, Inferior | 1 | 2007 | 148 | 0.070 |
Why?
|
| Aneurysm, Ruptured | 1 | 2006 | 54 | 0.060 |
Why?
|
| Heart Arrest | 1 | 2009 | 280 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2007 | 201 | 0.060 |
Why?
|
| Bacteremia | 1 | 2006 | 103 | 0.060 |
Why?
|
| Prenatal Diagnosis | 2 | 2009 | 110 | 0.060 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2009 | 151 | 0.060 |
Why?
|
| Ebstein Anomaly | 1 | 2004 | 5 | 0.060 |
Why?
|
| Stroke | 1 | 2013 | 1003 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2013 | 1066 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 272 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 1882 | 0.050 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2003 | 103 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2010 | 1061 | 0.050 |
Why?
|
| Vascular Resistance | 1 | 2022 | 103 | 0.050 |
Why?
|
| Pericardium | 1 | 2003 | 70 | 0.050 |
Why?
|
| C-Reactive Protein | 2 | 2015 | 196 | 0.050 |
Why?
|
| Pacemaker, Artificial | 1 | 2003 | 96 | 0.050 |
Why?
|
| Bicarbonates | 1 | 2022 | 58 | 0.050 |
Why?
|
| Gases | 1 | 2022 | 30 | 0.050 |
Why?
|
| Autopsy | 2 | 2014 | 125 | 0.050 |
Why?
|
| Reoperation | 2 | 2003 | 610 | 0.050 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2003 | 182 | 0.050 |
Why?
|
| Aortic Valve | 1 | 2003 | 251 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 385 | 0.050 |
Why?
|
| Arkansas | 2 | 2010 | 3 | 0.040 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2003 | 228 | 0.040 |
Why?
|
| Young Adult | 2 | 2009 | 6425 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2000 | 246 | 0.040 |
Why?
|
| Prevalence | 1 | 2023 | 1251 | 0.040 |
Why?
|
| Intensive Care Units | 2 | 2014 | 399 | 0.040 |
Why?
|
| Pregnancy | 2 | 2009 | 3064 | 0.040 |
Why?
|
| Tachycardia, Supraventricular | 1 | 1998 | 16 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2000 | 306 | 0.040 |
Why?
|
| Thrombosis | 1 | 2000 | 312 | 0.040 |
Why?
|
| Oxygen | 1 | 2022 | 747 | 0.030 |
Why?
|
| Aortopulmonary Septal Defect | 1 | 1996 | 1 | 0.030 |
Why?
|
| Lung | 1 | 2023 | 1305 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2000 | 1607 | 0.030 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1996 | 40 | 0.030 |
Why?
|
| Age Factors | 1 | 2000 | 1871 | 0.030 |
Why?
|
| Fibrinogen | 1 | 2015 | 52 | 0.030 |
Why?
|
| Adrenergic alpha-1 Receptor Agonists | 1 | 1994 | 4 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 1996 | 165 | 0.030 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1994 | 33 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 3486 | 0.030 |
Why?
|
| Norepinephrine | 1 | 1994 | 172 | 0.030 |
Why?
|
| Adrenal Glands | 1 | 2014 | 77 | 0.030 |
Why?
|
| Hyperbilirubinemia | 1 | 1993 | 21 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2012 | 4345 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 1994 | 437 | 0.020 |
Why?
|
| Hip | 1 | 2012 | 18 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2013 | 307 | 0.020 |
Why?
|
| Pulmonary Veins | 1 | 1993 | 93 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 73 | 0.020 |
Why?
|
| Rotation | 1 | 2012 | 91 | 0.020 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2012 | 36 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2014 | 290 | 0.020 |
Why?
|
| Body Height | 1 | 2012 | 100 | 0.020 |
Why?
|
| Adult | 2 | 2009 | 26940 | 0.020 |
Why?
|
| Patient Positioning | 1 | 2012 | 65 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2012 | 154 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 422 | 0.020 |
Why?
|
| Adrenal Cortex Function Tests | 1 | 2010 | 2 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 455 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 385 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2010 | 131 | 0.020 |
Why?
|
| Child Development | 1 | 2012 | 167 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 1935 | 0.020 |
Why?
|
| Photography | 1 | 2010 | 38 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2012 | 298 | 0.020 |
Why?
|
| Vincristine | 1 | 2009 | 108 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2009 | 72 | 0.020 |
Why?
|
| Laryngoscopy | 1 | 2009 | 47 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 878 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2009 | 95 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2009 | 281 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 2009 | 102 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2010 | 302 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 360 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2010 | 671 | 0.020 |
Why?
|
| Cytokines | 1 | 2012 | 813 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 1726 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2009 | 164 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2009 | 274 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2009 | 260 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 781 | 0.020 |
Why?
|
| Community-Acquired Infections | 1 | 2006 | 64 | 0.020 |
Why?
|
| Disease Progression | 1 | 2009 | 1485 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2782 | 0.010 |
Why?
|
| Infant Welfare | 1 | 2003 | 6 | 0.010 |
Why?
|
| Washington | 1 | 2003 | 49 | 0.010 |
Why?
|
| Tricuspid Atresia | 1 | 2003 | 4 | 0.010 |
Why?
|
| Child Welfare | 1 | 2003 | 39 | 0.010 |
Why?
|
| Pulmonary Valve | 1 | 2003 | 33 | 0.010 |
Why?
|
| Heart Septal Defects | 1 | 2003 | 32 | 0.010 |
Why?
|
| Polytetrafluoroethylene | 1 | 2003 | 75 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2003 | 199 | 0.010 |
Why?
|
| Morbidity | 1 | 2003 | 151 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 2003 | 185 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 2003 | 117 | 0.010 |
Why?
|
| Thromboembolism | 1 | 2003 | 124 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2003 | 351 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 2667 | 0.010 |
Why?
|
| Brain | 1 | 2012 | 2327 | 0.010 |
Why?
|
| Mitral Valve | 1 | 2003 | 267 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2003 | 1001 | 0.010 |
Why?
|
| Brimonidine Tartrate | 1 | 1994 | 1 | 0.010 |
Why?
|
| Yohimbine | 1 | 1994 | 7 | 0.010 |
Why?
|
| Prazosin | 1 | 1994 | 9 | 0.010 |
Why?
|
| Muscle Relaxation | 1 | 1994 | 18 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1994 | 45 | 0.010 |
Why?
|
| Quinoxalines | 1 | 1994 | 50 | 0.010 |
Why?
|
| Arginine | 1 | 1994 | 141 | 0.010 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 1993 | 18 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 1994 | 281 | 0.010 |
Why?
|
| Swine | 1 | 1994 | 593 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2003 | 2342 | 0.010 |
Why?
|
| Portal Vein | 1 | 1993 | 122 | 0.010 |
Why?
|
| Animals | 1 | 1994 | 27692 | 0.000 |
Why?
|